Bruker Corporation (BRKR) Reaches New 52-Week High at $35.51
Bruker Corporation (NASDAQ:BRKR) shares hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $35.51 and last traded at $35.37, with a volume of 159900 shares traded. The stock had previously closed at $35.22.
Several research analysts recently issued reports on BRKR shares. Zacks Investment Research upgraded shares of Bruker from a “hold” rating to a “buy” rating and set a $37.00 price target for the company in a research note on Wednesday, November 8th. BidaskClub upgraded shares of Bruker from a “hold” rating to a “buy” rating in a research note on Wednesday, August 16th. Cowen Inc reiterated a “hold” rating and issued a $29.00 price target on shares of Bruker in a research note on Friday, November 3rd. Citigroup Inc. increased their price target on shares of Bruker from $29.00 to $34.00 and gave the stock a “neutral” rating in a research note on Friday, November 3rd. Finally, Bank of America Corporation upgraded shares of Bruker from an “underperform” rating to a “neutral” rating and set a $34.00 price target for the company in a research note on Friday, November 3rd. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and four have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $29.64.
The stock has a market capitalization of $5,540.00, a P/E ratio of 30.23, a P/E/G ratio of 2.99 and a beta of 1.05. The company has a debt-to-equity ratio of 0.65, a current ratio of 2.60 and a quick ratio of 1.60.
Bruker (NASDAQ:BRKR) last announced its quarterly earnings results on Thursday, November 2nd. The medical research company reported $0.29 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.02. Bruker had a net margin of 8.85% and a return on equity of 25.83%. The firm had revenue of $435.60 million during the quarter, compared to analyst estimates of $415.45 million. During the same period in the previous year, the business posted $0.32 earnings per share. The business’s revenue for the quarter was up 10.6% on a year-over-year basis. research analysts anticipate that Bruker Corporation will post 1.19 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, December 22nd. Stockholders of record on Monday, December 4th will be paid a $0.04 dividend. The ex-dividend date is Friday, December 1st. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.45%. Bruker’s dividend payout ratio is presently 17.02%.
In other news, VP Mark Munch sold 21,061 shares of Bruker stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $29.97, for a total value of $631,198.17. Following the completion of the sale, the vice president now directly owns 60,524 shares in the company, valued at $1,813,904.28. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 35.20% of the company’s stock.
Several institutional investors and hedge funds have recently bought and sold shares of BRKR. Acrospire Investment Management LLC lifted its holdings in Bruker by 496.1% during the second quarter. Acrospire Investment Management LLC now owns 3,827 shares of the medical research company’s stock valued at $110,000 after purchasing an additional 3,185 shares in the last quarter. SG Americas Securities LLC purchased a new position in Bruker during the second quarter valued at approximately $111,000. Zions Bancorporation purchased a new position in Bruker during the third quarter valued at approximately $119,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Bruker by 11.3% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,599 shares of the medical research company’s stock valued at $133,000 after purchasing an additional 467 shares in the last quarter. Finally, Smithfield Trust Co. purchased a new position in Bruker during the second quarter valued at approximately $138,000. 66.27% of the stock is currently owned by institutional investors.
COPYRIGHT VIOLATION NOTICE: “Bruker Corporation (BRKR) Reaches New 52-Week High at $35.51” was posted by Watch List News and is owned by of Watch List News. If you are viewing this article on another site, it was copied illegally and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at https://www.watchlistnews.com/bruker-corporation-brkr-reaches-new-52-week-high-at-35-51/1729603.html.
Bruker Company Profile
Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.
Receive News & Ratings for Bruker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.